Arterioscler Thromb Vasc Biol

• 

  Publication Venue For

  • Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery Disease..  41:e265-e279. 2021
  • Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together..  41:1774-1776. 2021
  • Outside-in Signaling by Adventitial Fibroblasts..  41:711-713. 2021
  • Heparin-Induced Thrombocytopenia: A Focus on Thrombosis..  41:141-152. 2021
  • PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study..  40:2990-3003. 2020
  • A Novel Recurrent COL5A1 Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular Dysplasia..  40:2686-2699. 2020
  • High-Mobility Group Box-1 Is Associated With Obesity, Inflammation, and Subclinical Cardiovascular Risk Among Young Adults: A Longitudinal Cohort Study..  40:2776-2784. 2020
  • Macrophages Promote Aortic Valve Cell Calcification and Alter STAT3 Splicing..  40:e153-e165. 2020
  • Redox Activation of Nox1 (NADPH Oxidase 1) Involves an Intermolecular Disulfide Bond Between Protein Disulfide Isomerase and p47phox in Vascular Smooth Muscle Cells..  39:224-236. 2019
  • Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association..  39:e38-e81. 2019
  • USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis..  38:2295-2305. 2018
  • Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis..  38:1368-1380. 2018
  • Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function..  38:943-952. 2018
  • Cigarette Smoke Initiates Oxidative Stress-Induced Cellular Phenotypic Modulation Leading to Cerebral Aneurysm Pathogenesis..  38:610-621. 2018
  • Associations Between Residential Proximity to Traffic and Vascular Disease in a Cardiac Catheterization Cohort..  38:275-282. 2018
  • D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study..  37:2220-2227. 2017
  • Impact of Non-Vitamin K Antagonist Oral Anticoagulants From a Basic Science Perspective..  37:1812-1818. 2017
  • Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading..  37:1115-1126. 2017
  • Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model..  37:942-948. 2017
  • The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia..  36:984-993. 2016
  • Altered Maturation Status and Possible Immune Exhaustion of CD8 T Lymphocytes in the Peripheral Blood of Patients Presenting With Acute Coronary Syndromes..  36:389-397. 2016
  • Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease..  36:189-197. 2016
  • Gallstone Disease and the Risk of Ischemic Heart Disease..  35:2232-2237. 2015
  • Inhibited and Uninhibited Platelet Deposition Within a Thrombus: Does It Depend on the Antiplatelet Drug?.  35:2081-2082. 2015
  • Modulation of the Coagulation Cascade Using Aptamers..  35:2083-2091. 2015
  • Plasma Levels of Soluble Interleukin-2 Receptor α: Associations With Clinical Cardiovascular Events and Genome-Wide Association Scan..  35:2246-2253. 2015
  • Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study..  35:2048-2053. 2015
  • Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease..  35:1712-1722. 2015
  • G-protein-coupled receptors signaling pathways in new antiplatelet drug development..  35:500-512. 2015
  • Angiotensin II mobilizes spleen monocytes to promote the development of abdominal aortic aneurysm in Apoe-/- mice..  35:378-388. 2015
  • Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species..  34:2301-2309. 2014
  • Mitogen-activated protein kinase phosphatase-1 promotes neovascularization and angiogenic gene expression..  34:1020-1031. 2014
  • Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets..  33:1747-1752. 2013
  • Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells..  33:702-708. 2013
  • Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis..  32:2452-2460. 2012
  • Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice..  32:1436-1444. 2012
  • Macrophage imaging within human cerebral aneurysms wall using ferumoxytol-enhanced MRI: a pilot study..  32:1032-1038. 2012
  • G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors..  32:308-316. 2012
  • Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients..  31:2742-2748. 2011
  • Common variants in the periostin gene influence development of atherosclerosis in young persons..  31:1661-1667. 2011
  • Influence of physical activity and screen time on the retinal microvasculature in young children..  31:1233-1239. 2011
  • A critical role for chloride channel-3 (CIC-3) in smooth muscle cell activation and neointima formation..  31:345-351. 2011
  • Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development..  30:2372-2384. 2010
  • Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase..  30:2400-2407. 2010
  • An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation..  30:2234-2241. 2010
  • Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis..  30:2150-2155. 2010
  • Synergistic induction of mitogen-activated protein kinase phosphatase-1 by thrombin and epidermal growth factor requires vascular endothelial growth factor receptor-2..  30:1983-1989. 2010
  • DVT: a new era in anticoagulant therapy..  30:369-371. 2010
  • G-protein-coupled receptors as signaling targets for antiplatelet therapy..  29:449-457. 2009
  • Venous thromboembolism in pregnancy..  29:326-331. 2009
  • Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis..  28:2275-2281. 2008
  • CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden..  28:243-250. 2008
  • Tumor necrosis factor receptor-2 signaling attenuates vein graft neointima formation by promoting endothelial recovery..  28:284-289. 2008
  • VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling..  27:2619-2626. 2007
  • Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women..  27:1782-1787. 2007
  • Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils..  27:1850-1856. 2007
  • Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis..  27:1087-1094. 2007
  • Factor IXa inhibitors as novel anticoagulants..  27:722-727. 2007
  • Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression..  27:175-181. 2007
  • What does it take to make the perfect clot?.  26:41-48. 2006
  • Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice..  25:1671-1677. 2005
  • Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations..  25:861-866. 2005
  • Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia..  25:354-358. 2005
  • Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis..  25:418-423. 2005
  • Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells..  24:2277-2283. 2004
  • Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia..  24:2149-2154. 2004
  • Endothelium-targeted gene and cell-based therapies for cardiovascular disease..  24:1761-1774. 2004
  • Gene expression phenotypes of atherosclerosis..  24:1922-1927. 2004
  • Cell cycle-dependent regulation of smooth muscle cell activation..  24:845-850. 2004
  • Graft-extrinsic cells predominate in vein graft arterialization..  24:470-476. 2004
  • Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins..  23:1576-1582. 2003
  • Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease..  23:576-581. 2003
  • Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms..  23:483-488. 2003
  • Aortic aneurysms: It's all about the stress..  22:1948-1949. 2002
  • Platelets and thrombin generation..  22:1381-1389. 2002
  • Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN..  22:745-751. 2002
  • Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling..  22:560-565. 2002
  • Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin..  21:1152-1158. 2001
  • Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins: a mechanism for atherogenic lipid accumulation..  21:884-886. 2001
  • Adventitial fibroblasts: backstage journeymen..  21:722-723. 2001